Article
Assessment of the efficacy of the neuraminidase inhibitor oseltamivir against 2009 pandemic H1N1 influenza virus in ferrets.
Antiviral research - 1 Aug 2011
Govorkova Elena A, Marathe Bindumadhav M, Prevost Ashley, Rehg Jerold E, Webster Robert G
Abstract excerpt
Pandemic 2009 influenza A (H1N1) virus (H1N1pdm) is different from contemporary seasonal human viruses in that it can cause infection deep in the lungs of critical care patients. Here we establish a mammalian animal model and assessed the efficacy of the neuraminidase (NA) inhibitor oseltamivir treatment against H1N1pdm virus infection. Oseltamivir (25 mg/kg/day twice daily for 5 days) was orally administered to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
